The collaboration, combining Senseonics’ implantable glucose sensor with Beta Bionics’ insulin pump, is intended to simplify ...
It combines Senseonics’s CGM and Beta Bionics automated insulin delivery pump to simplify diabetes management and expand ...
Eversense 365 now works with iLet, combining a year of accurate glucose monitoring with fully adaptive, automated insulin delivery to reduce the ...
Beta Bionics, Inc. BBNX and Senseonics Holdings, Inc. SENS have commercially launched the integration of Beta Bionics' iLet ...
Diabetes management technology pioneer Beta Bionics has achieved another milestone, successfully amassing $100 million in its latest Series D equity funding round. The recent accomplishment surpasses ...
Estimated gross margin of 58.5% to 59.5% (no change versus previous guidance).
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Beta Bionics will use the new backing not only to fuel the rollout of its newly cleared iLet artificial pancreas technology, but also to continue developing additional automated systems for people ...
Beta Bionics (BBNX), a maker of insulin delivery devices, has disclosed terms for an upsized $113M initial public offering. In its latest SEC filing, the company said it was planning to offer 7.5M ...
Beta Bionics (BBNX), a maker of insulin delivery devices, has filed for a $100M initial public offering. Beta Bionics (BBNX) hopes to list its shares on Nasdaq under the symbol BBNX. Lead bookrunners ...